Christopher McNulty
2015
In 2015, Christopher McNulty earned a total compensation of $899.7K as Chief Financial Officer at InVivo Therapeutics Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $78,244 |
|---|---|
| Option Awards | $555,789 |
| Salary | $252,200 |
| Other | $13,513 |
| Total | $899,747 |
McNulty received $555.8K in option awards, accounting for 62% of the total pay in 2015.
McNulty also received $78.2K in non-equity incentive plan, $252.2K in salary and $13.5K in other compensation.
Rankings
In 2015, Christopher McNulty's compensation ranked 8,442nd out of 13,638 executives tracked by ExecPay. In other words, McNulty earned more than 38.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,442 out of 13,638 | 38th |
Division Manufacturing | 3,218 out of 5,190 | 38th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 424 out of 760 | 44th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 244 out of 466 | 48th |
Industry Surgical and Medical Instruments and Apparatus | 139 out of 293 | 53rd |
Source: SEC filing on April 27, 2018.
McNulty's colleagues
We found five more compensation records of executives who worked with Christopher McNulty at InVivo Therapeutics Holdings in 2015.
2015
Lorianne Masuoka
InVivo Therapeutics Holdings
Chief Medical Officer
2015
Mark Perrin
InVivo Therapeutics Holdings
Chief Executive Officer
2015
Thomas Ulich
InVivo Therapeutics Holdings
Chief Scientific Officer
2015
Tamara Joseph
InVivo Therapeutics Holdings
General Counsel
2015
Steven McAllister
InVivo Therapeutics Holdings